South Africa to Take Months to Register Vaccine After AstraZeneca Setback
(Bloomberg) -- South Africa will take about three months to register another Covid-19 vaccine for general use after the already approved AstraZeneca Plc shot proved only minimally effective in preventing mild disease caused by a variant of the virus first identified in South Africa.
The country has started inoculations of health workers as part of a study using Johnson & Johnson vaccines.
“There is likely to be a significant lag period,” Health Minister Zweli Mkhize said in a presentation to the National Council of Provinces on Thursday.
©2021 Bloomberg L.P.